(From left to right) Steffen Terberl/FU Berlin; Prof. Dr. Hannes Rothe/ICN Business School, photo: Ernestine von der Osten-Sacken16.12.2021
“BioTech does not get up and running on its own”
Brain City Berlin is one of the top locations in the health industry worldwide. However, in the BioTech sector, the region is not making full use of its innovation potential. At the same time, Berlin has a good chance of catching up with top clusters such as Cambridge or Boston. This is the conclusion of the “Deep Tech Futures Report 2021: Bio and HealthTech Startups in Berlin”
The study, which was led by Prof. Dr. Hannes Rothe, Associate Professor at the ICN Business School Berlin and co-founder of the Digital Innovation Hub of the Freie Universität Berlin (FU Berlin), compares Berlin with Cambridgeshire (Great Britain) and other locations in Germany on the basis of workshops, quantitative data analyses and interviews with founders, scientists, investors and technology transfer institutions, infrastructure providers and large companies.
Prof. Dr. Hannes Rothe and Steffen Terberl, Head of the start-up service of the FU Berlin, Profund Innovation, tell us in an interview more about the results of the report, the opportunities of Berlin as a location and how they could be used.
Dr. Rothe, for the recently published “Deep Tech Futures Report 20121” you focused on Bio and HealthTech start-ups. What was the trigger for doing the study?
Dr. Hannes Rothe: As a business computer science specialist with a focus on entrepreneurship, I have been involved with the BioTech sector since 2018. I found it unbelievable that there is a high concentration of large BioTech and HealthTech companies in other regions, but not in Berlin. Berlin is a great research location: We have three universities here alone that teach and research in the fields of natural sciences and technology, and with the Charité – Universitätsmedizin Berlin, we have the largest university hospital in Europe. Large research institutions such as the Max Delbrück Centre for Molecular Medicine (MDC) or the Max Planck Society (MPI) are also located here. But if you look at the start-up scene here, you will look in vain for large Health and BioTech start-ups – apart from Digital Health start-ups. We wanted to know how Berlin is positioned compared to other regions – and what can be done better if necessary.
Steffen Terberl: The planned technology and start-up centre FUBIC in Berlin-Dahlem should be completed in 2025. We will then also have a large proportion of laboratory space here. That was a reason for Profund Innovation to deal more closely with the topic of start-ups in the life sciences area.
An essential conclusion of the study “Bio and HealthTech Start-ups in Berlin” states: As an ecosystem for Bio and HealthTech start-ups, Berlin is not making full use of its potential. What does that mean exactly?
Dr. Hannes Rothe: When we refer to start-ups in Berlin, we usually mean digital start-ups. They are the Zalandos, the Rocket Internet and app developers in the field of digital health like Ada, but not like start-ups in biotechnology, diagnostics or medical technology. Such start-ups are here, but they are not the focus of investors. Berlin is the leader in Germany for Bio and HealthTech. Basic research is way ahead here anyway. As far as start-ups are concerned, there is still some potential in the capital region compared to top international clusters such as Cambridge or Boston.
Why is that?
Dr. Hannes Rothe: This is mainly due to the long development times of Bio and HealthTech products. And the new technologies still have to be brought onto the market. A health app, on the other hand, can be written within a few months. It then “only” has to be certified. So the process is much shorter. It also requires significantly less investment. For start-ups in the Bio and HealthTech sector, you need specific know-how and a completely different network. The requirements that founders face in this area therefore differ significantly.
Are there any other core issues?
Dr. Hannes Rothe: One of the key problems that we also identify in the study is: Although there are many Bio and HealthTech start-ups in Berlin, these usually remain small. This creates a scaling problem. This is a problem because no cycle can be built up. A start-up ecosystem works like this: As a start-up grows, it hires employees. Then, at best, it will be successful and sold. But the employees do not move away. Rather, they stay in the region and start something new. Successful ecosystems therefore feed themselves. Such an ecosystem already exists in Berlin in the digital sector – but that is not even remotely the case in the BioTech sector.
In the study you also mention a scaling problem...
Dr. Hannes Rothe: Yes, that’s right. We leave these companies in Berlin as small ones. We do not help them to grow. There are some resources, but ultimately a lot of that capacity is very distributed and not well connected. One reason for this is certainly: BioTech start-ups have so far received little attention because other areas have been more successful. This has changed with Corona. A company like Biontech, which in the meantime is making a substantial contribution to the German gross domestic product, can achieve a lot. There has certainly been a change. In Berlin, however, a lot of potential from basic research continues to be poorly transferred into growing start-ups.
Why is that so – isn’t Berlin generally committed to a well-functioning transfer of knowledge in the economy?
Dr. Hannes Rothe: Scientists who do research in the region tend to be too young and inexperienced. They are younger than in Boston and more inexperienced than in Cambridge. They do their doctorate and then start a business. They have no industry experience, no network and they do not know how to develop a medical product. Rather, they learn how to develop a medical product on-the-job. This is a problem because it takes a long time to develop such a product or diagnostic tool. There are many hurdles to be overcome. Whoever does not know these hurdles from the beginning, has to do some things twice – and that delays the process even more.
Basically, doesn’t that also apply to other areas?
Dr. Hannes Rothe: Yes, but it is especially serious in the health sector because it is so heavily regulated. Logically, a lot of attention is paid to safety. If it is found in phase two that something was not done right in phase one, you have to go back. If that is the case, 500,000 Euro can quickly be used up. And an investor may not be prepared to go through that twice. That is why, right from the start, start-ups in Boston or in Cambridge are provided with managers who have been through the process before,
That also exists in Berlin. Doesn’t the “Science & Startups” network, for example, comprise around 1,700 mentors? Is there a lack of experts here who can provide the support you mentioned?
Dr. Hannes Rothe: Yes to both of them. First of all, these experts are not co-founders, rather they are “only” mentors. This means that they are not an active part of the team, but only give their opinion. And secondly, there is a lack of people in Berlin who can provide this support because there are still no unicorns in Berlin’s Bio and HealthTech ecosystem. We do not have any billion dollar companies here that have already successfully gone through the process once or twice. Accordingly, there are fewer people in the capital region who can share this experience.
In the study you compare Cambridgeshire in Great Britain as a best practice example. What does Cambridge do differently than Berlin?
Dr. Hannes Rothe: Cambridge actually started ten years before Berlin - there is a very good book on it, “The Cambridge Phenomenon”. Cambridge went through a process similar to that of Berlin or Silicon Valley in the 1970s. The location initially started with information technology. At some point the hardware and software founders also invested outside their field. In the 1980s and early 1990s, Cambridge began investing in BioTech and HealthTech. We only started that in the 2000s. In that regard, there were large BioTech and HealthTech companies in Cambridge much earlier than here, which have now grown into unicorns. Other big players followed suit. Today Cambridge is THE leading BioTech cluster in Europe. AstraZeneca officially relocated its headquarters to Cambridge just a few weeks ago – because there is the aforementioned start-up ecosystem and cutting-edge research there – and because the company can set up joint labs there.
The study provides recommendations based on the comparison with Cambridge. This applies to addressing investors, for example.
Dr. Hannes Rothe: Precisely. Investors working in Cambridge do not invest in one, but in several start-ups. They know the ecosystem there. And they have an interest in ensuring that it lives and lasts. They are predominantly regional investors – but even international investors finance several start-ups there. This leads to these start-ups having more support. The exchange of information between the founders is also more intensive and the ecosystem tends to be promoted more strongly than in Berlin. Public sponsors are particularly active here. This is very important because in the Bio and HealthTech sector a long period of time has to be financed. But the process takes much longer than in Cambridge, for example, because there is a lack of private capital and because few help BioTech and HealthTech start-ups in a targeted way to raise private capital. As a result, our start-ups are usually dependent on public money for a very long time.
What could help the local start-ups?
Dr. Hannes Rothe: It is necessary, and this is also one of the core recommendations of the study, to build a platform that links the local industry more closely with the research-related incubators and the science parks of the city. Such a platform could also be used to find private regional investors who can support the start-ups with financed professionals. In principle, the chances for such a platform and therefore a boost for Bio and HealthTech start-ups in Berlin are good, because the leading local scientific institutions cooperate very intensively and are attaching increasing importance to the transfer of research results into practice.
Steffen Terberl: There is now also a blueprint for such a platform: the K.I.E.Z. - Artificial Intelligence Entrepreneurship Centre for the promotion of start-ups in the AI field, which was launched in September. In principle, we are doing exactly what we recommend as a model project for the BioTech area: We have very special services there. We are looking for investors who want to enter this area specifically, for talents and the right mentors. Individual institutions such as Profund Innovation cannot do this alone. We are all not big enough for that and we do not have the critical mass. But of course together it makes sense.
Dr. Hannes Rothe: There is another big difference between the BioTech ecosystems in Berlin and Cambridge: Our start-ups hold significantly fewer patents. One of the reasons for this is that the technology transfer that we are currently operating in the capital region is heavily focused on licenses. This means that the universities issue patents and ideally license fees then flow back to the universities. In Cambridge, the ideas belong to the founding companies, which, when they have grown enough, can stimulate further ideas. Start-ups develop further patents there after they have founded, and these also belong to them. This is usually not the case here. The problem is more likely to be accepted.
Steffen Terberl: However, this policy is justified. Universities cannot simply give away their intellectual property. At the moment, it only makes sense if investors get into the process early on and buy ideas out of the university on market terms. A start-up should be able to take care of patent management itself. The way the start-ups are currently positioned here at the universities, it is more positive for them if the respective university takes care of the patent management.
What tip would you give young teams that want to set up from within the university?
Steffen Terberl: We generally recommend that our start-ups focus on the market and potential customers relatively early on. Traditionally, scientists like to stay longer at the university. It is therefore important to integrate the business component into the team at an early stage. Normally, very homogeneous teams come to us that have developed out of a working group. Most of the time, they completely lack business understanding initially. One of our concerns is to bring this component in as quickly as possible.
Dr. Hannes Rothe: There are courses for science-based start-ups that life science students can also make use of. These help first of all to develop a basic understanding of what it means to found a start-up. It is also about learning to understand the language of business. In addition, there is now a Berlin Startup Scholarship programme for the health industry. This is a small amount of money, but a good way to get going in a start-up. In addition, it is of course important to get in touch with the incubators. However, the problem with the lack of proximity to industry remains. At the moment, everyone has to be very active themselves. BioTech unfortunately does not get up and running on its own.
The research group and partner institutions are planning a joint event on the report in spring 2022. More information about the email distribution list: https://mailchi.mp/1402c91c5174/towards-bio-futures-berlin
- „Deep Tech Futures Report 2021: Bio- und HealthTech Startups in Berlin“ (Infos und Download, German only)
Transfer – Stories EUREF AG©Gasometertour.deTransfer – StoriesOn the site of the EUREF-Campus in Berlin-Schoeneberg the transfer of knowledge works particularly impressively.→
Hands-on Energy Transition
Transfer – Stories © SCC Events/Norbert WilhelmiTransfer – StoriesInterview with Brain City Ambassador Prof. Dr. Gabriele Mielke, Vice President of the VICTORIA | International University of Applied Sciences and also…→
"Major Events Affect Life in the City on Different Levels”
Transfer – Stories Photo: Ernestine von der Osten-Sacken (vdo)Transfer – StoriesThe Charlottenburg Innovation Centre CHIC hosts around 50 start-ups. Situated at Brain City Berlin’s “Zukunftsort” Campus Charlottenburg, the CHIC…→
CHIC - Business Incubator at a "Zukunftsort’"
Transfer – Stories Photo: Mall Anders/Matthew CrabbeTransfer – Stories“Mall Anders” is an open learning laboratory which was launched by the FU Berlin, HU Berlin, TU Berlin and Charité – Universitätsmedizin Berlin in a…→
Science in a Shopping Centre
Transfer – Stories BHT/Martin GaschTransfer – StoriesInterview: Brain City Ambassador Dr-Ing. Ivo Boblan, Professor of the Humanoid Robotics Study Programme at the Berliner Hochschule für Technik, and…→
“Robots Can Save us a Great Deal of Work”
Transfer – Stories (Left to right) Prof. Christian Matzdorf, Police commissioner Turgay Akkaya, Stefan Graf Finck von Finckenstein, Photo: HWR Berlin / Sylke SchumannTransfer – StoriesPolice commissioner Turgay Akkaya has developed an anti-stalking app as part of his Bachelor’s project at the HWR Berlin. At the beginning of January…→
A Preventive App Against Stalking
Transfer – Stories Photo: Christina Lüdtke (private source)Transfer – StoriesFour universities, one network: The network “Science & Startups” groups the start-up services of the universities united in the Berlin University…→
Wide-ranging Support for University Start-ups
Transfer – Stories Photo: privateTransfer – StoriesA guest contribution by Brain City Ambassador Dr. Anna Klippstein, professor of finance and Eliyahu Mätzschker, student at Touro College Berlin.→
The Pandemic and its Impact on the Capital Market
Transfer – Stories Credit: André BakkerTransfer – StoriesA guest contribution by Brain City Ambassador Prof. Dr Anabel Ternès von Hattburg, Professor for International Business Administration at the SRH…→
Getting on Board with Digitality
Transfer – Stories Swen Hutter (Foto: David Ausserhofer), Gesine Höltmann (Foto: Martina Sander)Transfer – StoriesA guest contribution by Gesine Höltmann, research assistant and Swen Hutter, Deputy Director at the Centre for Civil Society Research.→
Polarisation and Cohesion in the Corona Crisis: a Look at Civil Society
Transfer – Stories Foto: "Lucid Dream", Elena Kunau and Mariya YordanovaTransfer – StoriesARTIFICIAL REALITY – VIRTUAL INTELLIGENCE is the name of an exhibition that can be seen from 8 to 12 September as part of Ars Electronica Garden…→
Interaction via Emotion
Transfer – Stories Credit: Peter Himsel/Campus Berlin-Buch GmbHTransfer – StoriesThe Campus Berlin-Buch in the north of Brain City Berlin has grown to become one of Europe’s largest business and research centres for life sciences.→
A Vibrant Healthcare Network
Transfer – Stories Credit: Markus KrutzikTransfer – StoriesDr. Markus Krutzik, Head of the Joint Lab Integrated Quantum Sensors (IQS), on the "Wissenschaft trifft Wirtschaft" (Science Meets Business") event…→
"I am Fascinated by the Possibilities of Quantum Sensors"
Transfer – Stories Foto: ESCP Business School BerlinTransfer – StoriesWhat to do when distance is suddenly the order of the day? A guest contribution by Dr. René Mauer, Professor of Entrepreneurship und Innovation at…→
Using Whiteboards to Combat Digital Fatigue
Transfer – Stories Credit: Alexander Rentsch/HTW BerlinTransfer – StoriesBrain City Ambassador Prof. Dr. Florian Koch of HTW Berlin brings together science, business and civil society in his research.→
“Increasing Urbanisation also Creates Opportunities”
Transfer – Stories Credit: Rudolf GrillborzerTransfer – StoriesGuest contribution by Brain City Ambassador Dr.-Ing. Onur Günlü, Technische Universität Berlin.→
Exploring the "ultimate limits"
Transfer – Stories Credt: Startup Incubator BerlinTransfer – StoriesThe Startup Incubator Berlin at the Berlin School of Economics and Law is particularly successful in supporting founder teams – as proved by the fact…→
“We Bring Ideas to Market”
Transfer – Stories Credit: Mimi Thian on UnsolashTransfer – StoriesGuest Contribution by Brain City Ambassador Dr. Petyo Budakov, University of Europe for Applied Sciences.→
“Proudly presenting Brain City Berlin in 2020”
Transfer – Stories Susanne Plaumann (private)Transfer – StoriesInterview with Brain City Ambassador Susanne Plaumann M.A., Central women's representative at the Beuth University of Applied Sciences Berlin.→
“Careers are now easier to plan for women scientists”
Transfer – Stories Adi Goldstein auf UnsplashTransfer – StoriesStadtManufaktur Berlin conceptually unites research projects of the TU Berlin under a single roof. The long-term goal of this “open laboratory…→
Science in Dialogue with the City
Transfer – Stories Falk WeißTransfer – StoriesThe knowledge portal “humboldts17” presents current research on the subject of sustainability and welcomes open dialogue with the general public. The…→
17 Goals for the Future
Transfer – Stories Foto: Olga Makarova privatTransfer – StoriesBrain City Ambassador Olga Makarova reflects on being a microbiologist during the pandemic, and the urgent need for microbiology literacy in society.→
Guest Contribution: COVID-19 and microbiology literacy
Transfer – Stories HIIGTransfer – StoriesBrain City-Interview with Prof. Dr. Wolfgang Schulz, Research Director at the Alexander von Humboldt Institute for Internet and Society (HIIG).→
“A sustainable goal of our work is to make clear what the technology can actually do”
Transfer – Stories HTW BerlinTransfer – StoriesAn interview with Brain City Ambassador Prof. Dr. Kai Reinhardt. On October 28, he will be speaking at the second SpreeTalk at HTW University of…→
“The pandemic has been a catalyst for digitalization”
Transfer – Stories dentalXr.aiTransfer – StoriesdentalXrai is the first dental start-up to be spun off the Charité. It was launched via the accelerator of the Berlin Institute of Health (BIH). We…→
Artificial intelligence in the fight against tooth decay
Transfer – Stories Anna Raysyan (private)Transfer – StoriesBrain City Ambassador Anna Raysyan has been living in Berlin for 3,5 years now. She is a PhD student at the Bundesanstalt für Materialforschung und…→
Guest Contribution: “Berlin likes the bold!”
Transfer – Stories ©Berlin Partner für Wirtschaft und TechnologieTransfer – StoriesMany top-class researchers and scientists are being attracted to Brain City Berlin every year. The Dual Career Network Berlin helps partners of…→
Dual Career Network Berlin: getting a good start in Berlin
Transfer – Stories ©Matthias PicketTransfer – StoriesDr. Anne Schreiter, Managing Director of the German Scholars Organization (GSO), reveals in the Brain City interview what alternative career…→
"Science is not just about research"
Transfer – Stories © Pocky Lee on UnsplashTransfer – StoriesMatches in front of empty stadiums, virtual marathons, and many postponed events. Brain City Ambassador Professor Gabriele Mielke is tracking the…→
"Now is the time for innovators"
Transfer – Stories © AW Creative on UnsplashTransfer – StoriesJuggling a degree course or teaching with the extra burden of the care of children or other family members is not an easy task. Both students and…→
From “Zoo School” to “Maternity Protection”: family-friendly universities
Transfer – Stories © HTW Berlin / Nikolas FahlbuschTransfer – StoriesTeaching is currently only taking place online. Guest author Dr Dorothee Haffner, professor for Museology at HTW Berlin - University of Applied…→
Guest contribution: "Online teaching is more engaging than I thought"
Transfer – Stories Franziska SattlerTransfer – StoriesIn the interview: Brain City ambassador Franziska Sattler on her series of events "Kaffeeklatsch mit Wissenschaft" (Talking Science over Coffee) at…→
"Science needs the trust of society"
Transfer – Stories Fotocredit: Ortner & Ortner / SiemensTransfer – StoriesSiemensstadt 2.0 is a place of the future. The Berlin Senate has approved 9.9 million euros for the first research project "Electrical Drive…→
Siemensstadt 2.0: Research and industry closely linked
Transfer – Stories ©Credit Silke Oßwald/FMPTransfer – StoriesBrain City interview: Professor Dr. Volker Haucke, Director at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) and Professor of…→
In the balancing act between detail and overall concept
Transfer – Stories © hj barraza/UnsplashTransfer – StoriesOur guest author Dr Barbara Schäuble is Professor for Diversity-Conscious Approaches in the Theory and Practice of Social Work at ASH Berlin and a…→
Guest contribution: A sudden change of course - classes moved online
Transfer – Stories ©DexLeChemTransfer – StoriesLaunching a start-up while at university? Sonja Jost's success shows the way. Together with three fellow students, she founded DexLeChem after…→
"Bringing new knowledge to the market is very important to us"
Transfer – Stories ©Ivar Veermäe / Centre for EntrepreneurshipTransfer – StoriesBrain City Berlin is the German capital of start-ups. Many young companies have successfully been founded through Berlin and Brandenburg based…→
"Society in particular benefits from high-tech start-ups" - university survey enters its third round
Transfer – Stories ©BIH|Thomas RafalzykTransfer – StoriesAt the Berlin Institute of Health (BIH) the main focus is on "translational research" - the transfer of findings from the research lab into clinical…→
“There are now many great female scientists, achieving great things”
Transfer – Stories ©fotografixx - istockphoto.comTransfer – StoriesIn the digital age learning behaviour changes profoundly. It is student-centered and technology rich. As a member of the Erasmus+ funded project…→
Exploring the future of learning
Transfer – Stories © Brain City BerlinTransfer – StoriesResearch results quickly and easily accessible online: The Open Access movement is campaigning for a paradigm shift in the field of publications and…→
Open Access: free knowledge for everyone
Transfer – Stories ©ESCP EUROPETransfer – Stories29.10.2019 | Professor Andreas Kaplan is a Brain City Berlin ambassador and Rector of ESCP Europe Business School Berlin. The economist's research is…→
"We have to be able to take everyone on the journey."
Transfer – Stories Gudrun Piechotta-HenzeTransfer – StoriesIn time for the 2020/21 winter semester, ASH, the Alice Salomon University of Applied Sciences Berlin, is launching the first bachelor's degree to…→
"We have to completely rethink nursing!" | 27.09.2019
Transfer – Stories ©Humboldt-Universität zu Berlin/Matthias HeydeTransfer – StoriesThe courses offered by the HUWISU Summer University are varied and exciting, the target group is international: students from abroad who come to…→
When Berlin becomes one large seminar room ... | 15.08.2019
Transfer – Stories [Translate to English:]Transfer – StoriesThe literary scholar Dr. Betiel Wasihun was traveling for science. After stops in Heidelberg, Yale, and Oxford, it brought her to Berlin two years…→
“Berlin is a perfect location. Especially if you don’t want to pursue just a single avenue of scientific work.” | 12.08.2019
Transfer – Stories [Translate to English:] Berlin University Alliance/Matthias HeydeTransfer – StoriesTogether we are stronger. And also more successful. As the "Berlin University Alliance," the Technische Universität Berlin, the Freie Universität…→
Congratulations: The “Berlin University Alliance“ receives funding of the Excellence Strategy |19.07.2019
Transfer – Stories [Translate to English:] David Ausserhofer/IGBTransfer – StoriesBerlin is one of the most water-rich cities in Germany. But climate change does not stop at the Havel, Spree or Wannsee either. Dr. Michael Hupfer is…→
"We're trying to take a look into the future." | 04.07.2019
Transfer – Stories [Translate to English:] Helena Lopes / UnsplashTransfer – StoriesSend a digital lollipop or delicate fragrance notes via email or let the wind virtually blow against your face - research makes it possible. Learn…→
Experiencing the digital world with all senses | 18.06.2019
Transfer – Stories [Translate to English:] HZB/M. SetzpfandtTransfer – StoriesIn these times of fake news and pseudo-scientific publications, many people find it difficult to distinguish legitimate from dubious content. Only 54%…→
"Science needs to make us curious" | 11.06.2019
Transfer – Stories [Translate to English:] Tim LandgrafTransfer – StoriesBrain City Berlin is considered one of the leading locations in Germany working on artificial intelligence. About 30% of all German AI companies are…→
Fish, bees, and self-driving cars | 07.06.2019
Transfer – Stories [Translate to English:]Transfer – StoriesScience and cultural heritage, freely accessible to everyone at any time on the Internet: The Open Access movement is promoting a paradigm shift in…→
Knowledge for All - Open Access in Berlin | 28.03.2019
Transfer – Stories [Translate to English:] Thomas Rosenthal - Museum für Naturkunde BerlinTransfer – Stories660 million euros in 10 years: The Natural History Museum Berlin - Museum für Naturkunde Berlin receives financial support for the further development…→
Future of the Museum für Naturkunde Berlin | 14.01.2019
Transfer – Stories [Translate to English:]Transfer – StoriesSpace exploration is experiencing a revolution thanks to commercialization by such companies as Elon Musk's SpaceX. But did you know that more facets…→
From Berlin to the moon: the space industry is booming in Berlin | 03.09.2018